UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 128

Sortiert nach

Mutations in SCN10A Are Responsible for a Large Fraction of Cases of Brugada Syndrome

Journal of the American College of Cardiology, 2014-07, Vol.64 (1), p.66-79

2014

Link zum Volltext

Verfügbarkeit prüfen

Cardiac late Na+ current: Proarrhythmic effects, roles in long QT syndromes, and pathological relationship to CaMKII and oxidative stress

Heart rhythm, 2015-02, Vol.12 (2), p.440-448

2015

Link zum Volltext

Verfügbarkeit prüfen

The arrhythmogenic consequences of increasing late INa in the cardiomyocyte

Cardiovascular research, 2013-09, Vol.99 (4), p.600-611

2013

Link zum Volltext

Verfügbarkeit prüfen

A Missense Variant in PLEC Increases Risk of Atrial Fibrillation

Journal of the American College of Cardiology, 2017-10, Vol.70 (17), p.2157-2168

2017

Link zum Volltext

Verfügbarkeit prüfen

Meta-Analysis of Mechano-Sensitive Ion Channels in Human Hearts: Chamber- and Disease-Preferential mRNA Expression

International journal of molecular sciences, 2023-06, Vol.24 (13), p.10961

2023

Link zum Volltext

Verfügbarkeit prüfen

A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias

The Journal of pharmacology and experimental therapeutics, 2013-01, Vol.344 (1), p.23

2013

Link zum Volltext

Verfügbarkeit prüfen

A computational model predicts adjunctive pharmacotherapy for cardiac safety via selective inhibition of the late cardiac Na current

Journal of molecular and cellular cardiology, 2016-10, Vol.99, p.151-161

2016

Link zum Volltext

Verfügbarkeit prüfen

If inhibition in the atrioventricular node by ivabradine causes rate-dependent slowing of conduction and reduces ventricular rate during atrial fibrillation

Heart rhythm, 2014-12, Vol.11 (12), p.2288-2296

2014

Link zum Volltext

Verfügbarkeit prüfen

Small Conductance Ca2 +-Activated K+ (SK) Channel mRNA Expression in Human Atrial and Ventricular Tissue: Comparison Between Donor, Atrial Fibrillation and Heart Failure Tissue

Frontiers in physiology, 2021-04, Vol.12, p.650964-650964

2021

Link zum Volltext

Verfügbarkeit prüfen

Selective late sodium current inhibitor GS‐458967 suppresses Torsades de Pointes by mostly affecting perpetuation but not initiation of the arrhythmia

British journal of pharmacology, 2018-06, Vol.175 (12), p.2470-2482

2018

Link zum Volltext

Verfügbarkeit prüfen

Pro-arrhythmic effects of low plasma [K+] in human ventricle: An illustrated review

Trends in cardiovascular medicine, 2018-05, Vol.28 (4), p.233-242

2018

Link zum Volltext

Verfügbarkeit prüfen

Unmasking atrial repolarization to assess alternans, spatiotemporal heterogeneity, and susceptibility to atrial fibrillation

Heart rhythm, 2016-04, Vol.13 (4), p.953-961

2016

Link zum Volltext

Verfügbarkeit prüfen

Deranged sodium to sudden death

The Journal of physiology, 2015-03, Vol.593 (6), p.1331-1345

2015

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of the cardiac late sodium current with eleclazine protects against ischemia-induced vulnerability to atrial fibrillation and reduces atrial and ventricular repolarization abnormalities in the absence and presence of concurrent adrenergic stimulation

Heart rhythm, 2016-09, Vol.13 (9), p.1860-1867

2016

Link zum Volltext

Verfügbarkeit prüfen

Eleclazine, a new selective cardiac late sodium current inhibitor, confers concurrent protection against autonomically induced atrial premature beats, repolarization alternans and heterogeneity, and atrial fibrillation in an intact porcine model

Heart rhythm, 2016-08, Vol.13 (8), p.1679-1686

2016

Link zum Volltext

Verfügbarkeit prüfen

Eleclazine, an inhibitor of the cardiac late sodium current, is superior to flecainide in suppressing catecholamine-induced ventricular tachycardia and T-wave alternans in an intact porcine model

Heart rhythm, 2017-03, Vol.14 (3), p.448-454

2017

Link zum Volltext

Verfügbarkeit prüfen

The Selective Cardiac Late Sodium Current Inhibitor GS-458967 Suppresses Autonomically Triggered Atrial Fibrillation in an Intact Porcine Model

Journal of cardiovascular electrophysiology, 2015-12, Vol.26 (12), p.1364-1369

2015

Link zum Volltext

Verfügbarkeit prüfen

Effect of ranolazine on ventricular repolarization in class III antiarrhythmic drug-treated rabbits

Heart rhythm, 2012-12, Vol.9 (12), p.2051-2058

2012

Link zum Volltext

Verfügbarkeit prüfen

Simulation and mechanistic investigation of the arrhythmogenic role of the late sodium current in human heart failure

PloS one, 2012-03, Vol.7 (3), p.e32659-e32659

2012

Link zum Volltext

Verfügbarkeit prüfen

Use-dependent block of cardiac late Na+ current by ranolazine

Heart rhythm, 2009-11, Vol.6 (11), p.1625-1631

2009

Link zum Volltext

Verfügbarkeit prüfen

Reduction of repolarization reserve unmasks the proarrhythmic role of endogenous late Na+ current in the heart

American journal of physiology. Heart and circulatory physiology, 2009-09, Vol.297 (3), p.H1048-H1057

2009

Link zum Volltext

Verfügbarkeit prüfen

Selective late INa inhibition by GS-458967 exerts parallel suppression of catecholamine-induced hemodynamically significant ventricular tachycardia and T-wave alternans in an intact porcine model

Heart rhythm, 2015-12, Vol.12 (12), p.2508-2514

2015

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological rescue of human K+ channel long-QT2 mutations: Human ether-a-go-go-related gene rescue without block

Circulation (New York, N.Y.), 2002-06, Vol.105 (24), p.2830-2835

2002

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of SCN5A in mouse heart mimics human syndrome of enhanced atrioventricular nodal conduction

Heart rhythm, 2015-05, Vol.12 (5), p.1036-1045

2015

Link zum Volltext

Verfügbarkeit prüfen

New Insights into the Beneficial Electrophysiologic Profile of Ranolazine in Heart Failure: Prevention of Ventricular Fibrillation With Increased Postrepolarization Refractoriness and Without Drug-Induced Proarrhythmia

Journal of cardiac failure, 2012-12, Vol.18 (12), p.939-949

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 128

Suche als RSS-Feed

Aktive Filter

KollektionSpringer Nature - Connect here FIRST to enable access

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(126)

Publikationsform

Sprache

Englisch
(128)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Life Sciences & Biomedicine
(58)
Animals
(48)
Cardiac & Cardiovascular Systems
(39)
Cardiovascular System & Cardiology
(39)
Humans
(36)
Ranolazine
(26)
Physiology
(23)
Male
(20)
Sodium Channel Blockers - Pharmacology
(19)
Cardiovascular
(18)
Action Potentials - Drug Effects
(17)
Myocytes, Cardiac - Drug Effects
(17)
Myocytes, Cardiac - Metabolism
(17)
Piperazines - Pharmacology
(17)
Acetanilides - Pharmacology
(16)
Rabbits
(16)
Female
(15)
Anti-Arrhythmia Agents - Pharmacology
(14)
Disease Models, Animal
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mutations in SCN10A Are Responsible for a Large Fraction of Cases of Brugada Syndrome

Cardiac late Na+ current: Proarrhythmic effects, roles in long QT syndromes, and pathological relationship to CaMKII and oxidative stress

The arrhythmogenic consequences of increasing late INa in the cardiomyocyte

A Missense Variant in PLEC Increases Risk of Atrial Fibrillation

Meta-Analysis of Mechano-Sensitive Ion Channels in Human Hearts: Chamber- and Disease-Preferential mRNA Expression

A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias

A computational model predicts adjunctive pharmacotherapy for cardiac safety via selective inhibition of the late cardiac Na current

If inhibition in the atrioventricular node by ivabradine causes rate-dependent slowing of conduction and reduces ventricular rate during atrial fibrillation

Small Conductance Ca2 +-Activated K+ (SK) Channel mRNA Expression in Human Atrial and Ventricular Tissue: Comparison Between Donor, Atrial Fibrillation and Heart Failure Tissue

Selective late sodium current inhibitor GS‐458967 suppresses Torsades de Pointes by mostly affecting perpetuation but not initiation of the arrhythmia

Pro-arrhythmic effects of low plasma [K+] in human ventricle: An illustrated review

Unmasking atrial repolarization to assess alternans, spatiotemporal heterogeneity, and susceptibility to atrial fibrillation

Deranged sodium to sudden death

Inhibition of the cardiac late sodium current with eleclazine protects against ischemia-induced vulnerability to atrial fibrillation and reduces atrial and ventricular repolarization abnormalities in the absence and presence of concurrent adrenergic stimulation

Eleclazine, a new selective cardiac late sodium current inhibitor, confers concurrent protection against autonomically induced atrial premature beats, repolarization alternans and heterogeneity, and atrial fibrillation in an intact porcine model

Eleclazine, an inhibitor of the cardiac late sodium current, is superior to flecainide in suppressing catecholamine-induced ventricular tachycardia and T-wave alternans in an intact porcine model

The Selective Cardiac Late Sodium Current Inhibitor GS-458967 Suppresses Autonomically Triggered Atrial Fibrillation in an Intact Porcine Model

Effect of ranolazine on ventricular repolarization in class III antiarrhythmic drug-treated rabbits

Simulation and mechanistic investigation of the arrhythmogenic role of the late sodium current in human heart failure

Use-dependent block of cardiac late Na+ current by ranolazine

Reduction of repolarization reserve unmasks the proarrhythmic role of endogenous late Na+ current in the heart

Selective late INa inhibition by GS-458967 exerts parallel suppression of catecholamine-induced hemodynamically significant ventricular tachycardia and T-wave alternans in an intact porcine model

Pharmacological rescue of human K+ channel long-QT2 mutations: Human ether-a-go-go-related gene rescue without block

Overexpression of SCN5A in mouse heart mimics human syndrome of enhanced atrioventricular nodal conduction

New Insights into the Beneficial Electrophysiologic Profile of Ranolazine in Heart Failure: Prevention of Ventricular Fibrillation With Increased Postrepolarization Refractoriness and Without Drug-Induced Proarrhythmia

Aktive Filter

Suchergebnisse filtern